PlainRecalls
FDA Drug Moderate Class II Terminated

PAIN AID ESF- (Acetaminopehn USP 250mg, Asprin USP 250mg Caffeine 65mg) coated, bulk OTC tablets packaged in corrugated boxes lined with 2 polyethylene bags 100 lb, ULTRAtab Laboratories, Inc. NDC# 62959-560-00, Product Code M560L

Reported: January 12, 2022 Initiated: November 29, 2021 #D-0327-2022

Product Description

PAIN AID ESF- (Acetaminopehn USP 250mg, Asprin USP 250mg Caffeine 65mg) coated, bulk OTC tablets packaged in corrugated boxes lined with 2 polyethylene bags 100 lb, ULTRAtab Laboratories, Inc. NDC# 62959-560-00, Product Code M560L

Reason for Recall

CGMP Deviations: failed stability results, inadequate laboratory investigations,

Details

Units Affected
14 bulk lots (approximately 1,987,951 tablets each)
Distribution
Product was distributed to one customer who may have further distributed the product.
Location
Highland, NY

Frequently Asked Questions

What product was recalled?
PAIN AID ESF- (Acetaminopehn USP 250mg, Asprin USP 250mg Caffeine 65mg) coated, bulk OTC tablets packaged in corrugated boxes lined with 2 polyethylene bags 100 lb, ULTRAtab Laboratories, Inc. NDC# 62959-560-00, Product Code M560L. Recalled by ULTRAtab Laboratories, Inc.. Units affected: 14 bulk lots (approximately 1,987,951 tablets each).
Why was this product recalled?
CGMP Deviations: failed stability results, inadequate laboratory investigations,
Which agency issued this recall?
This recall was issued by the FDA Drug on January 12, 2022. Severity: Moderate. Recall number: D-0327-2022.